CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma

Journal of Translational Medicine

Volumn 3, Issue , 2005, Pages

  Somasundaram, Rajasekharan ^a   Caputo, Laura ^a   Guerry, Du Pont ^b   Herlyn, Dorothee ^a  

^a WISTAR INSTITUTE   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CD3 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; HLA ANTIBODY; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MELANOMA VACCINE; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; BREAST CELL; CARCINOMA CELL; CASE REPORT; CELL STRAIN K 562; COLORECTAL CARCINOMA; CYTOTOXIC T LYMPHOCYTE; DAUDI CELL; DRUG DESIGN; GLIOMA CELL; HUMAN; HUMAN CELL; LYMPHOID CELL LINE; MALE; MELANOMA; MELANOMA CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; TUMOR CELL DESTRUCTION;

EID: 27944455729     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-3-41     Document Type: Article

References (17)

1. Castelli C, Rivoltini L, Andreola G, Carrabba M, Renkvist N, Parmiani G: T-cell recognition of melanoma-associated antigens. J Cell Physiol 2000, 182:323-331.
2. Renkvist N, Castelli C, Robbins PF, Parmiani G: A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother 2001, 50:3-15.
3. de Vries JE, Spits H: Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. J Immunol 1984, 132:510-519.
4. Fossati G, Anichini A, Parmiani G: Melanoma cell lysis by human CTL clones: differential involvement of T3, T8 and HLA antigens. Int J Cancer 1987, 39:689-694.
5. Mukherji B, Guha A, Chakraborty NG, Sivanandham M, Nashed AL, Sporn JR, Ergin MT: Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. J Exp Med 1989, 169:1961-1976.
6. Topalian SL, Solomon D, Rosenberg SA: Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol 1989, 142:3714-3725.
7. Hsu M-Y, Elder DE, Herlyn M: Melanoma: The Wistar Institute (WM) cell lines. In Human Cell Culture. Edited by Masters JRW, Palsson B. Great Britain: Kluwer Academic Publishers; 1999: 259-274.
8. Juhasz I, Albelda SM, Elder DE, Murphy GF, Adachi K, Herlyn D, Valyi-Nagy IT, Herlyn M: Growth and invasion of human melanomas in human skin grafted to immunodeficient mice. Am J Pathol 1993, 143:528-537.
9. Jacob L, Somasundaram R, Smith W, Monos D, Basak S, Marincola F, Pereira S, Herlyn D: Cytotoxic T-cell clone against rectal carcinoma induced by stimulation of a patient's peripheral blood mononuclear cells with autologous cultured tumor cells. Int J Cancer 1997, 71:325-332.
10. +, HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells. Int J Cancer 2000, 85:253-259.
11. Herlyn M, Koprowski H: Melanoma antigens: immunological and biological characterization and clinical significance. Annu Rev Immunol 1988, 6:283-308.
12. Horwitz DA, Gray JD, Behrendsen SC, Kubin M, Rengaraju M, Ohtsuka K, Trinchieri G: Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum 1998, 41:838-844.
13. Somasundaram R, Jacob L, Swoboda R, Caputo L, Song H, Basak S, Monos D, Peritt D, Marincola F, Cai D, Birebent B, Bloome E, Kim J, Berencsi K, Mastrangelo M, Herlyn D: Inhibition of cytolytic T lymphocyte proliferation by autologous CD4+/CD25+ regulatory T cells in a colorectal carcinoma patient is mediated by transforming growth factor-beta. Cancer Res 2002, 62:5267-5272.
14. Kubo H, Abe J, Obata F, Nakajima H, Tsunoda M, Ogawa A, Nakayama S, Beck Y, Kohsaka T, Darrow TL, Abdel-Wahab Z, Saida T, Takiguchi M: Dual recognition of a human cytotoxic T-cell clone for melanoma antigens. Cancer Res 1996, 56:2368-2374.
15. Barnd DL, Lan MS, Metzgar RS, Finn OJ: Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci U S A 1989, 86:7159-7163.
16. Jerome KR, Domenech N, Finn OJ: Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. J Immunol 1993, 151:1654-1662.
17. Ioannides CG, Fisk B, Jerome KR, Irimura T, Wharton JT, Finn OJ: Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J Immunol 1993, 151:3693-3703.